Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis
- 1 December 1985
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 28 (6) , 751-755
- https://doi.org/10.1128/aac.28.6.751
Abstract
Amphotericin B and N-D-ornithyl amphotericin B methyl ester were compared for therapeutic efficacies against experimentally induced cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis in rabbits. Antifungal activity of the two polyenes in vitro was similar for the yeasts used in these experiments. N-D-ornithyl amphotericin B methyl ester gave a slightly higher concentration in serum than amphotericin B did, but both drugs had similar elimination curves, and penetration into the cerebrospinal fluid was poor for both. Despite these similarities between the two polyenes, amphotericin B was much more effective than N-D-ornithyl amphotericin B methyl ester in the treatment of cryptococcal meningitis in rabbits. For C. albicans endocarditis, both polyenes had similar cure rates, but in vitro measurement of fungicidal activity in serum did not predict treatment outcome. For C. albicans pyelonephritis, both polyenes showed efficacy; because higher doses of the less toxic methyl ester could be used, it sterilized the urinary tract more often than amphotericin B. These studies indicate that in vivo and in vitro experiments may be needed to predict the results of treatment with polyenes.This publication has 27 references indexed in Scilit:
- Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicansAntimicrobial Agents and Chemotherapy, 1985
- Activities of the modified polyene N-D-ornithyl amphotericin methyl ester and the azoles ICI 153066, Bay n 7133, and Bay l 9139 compared with those of amphotericin B and ketoconazole in the therapy of experimental blastomycosisAntimicrobial Agents and Chemotherapy, 1985
- In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl esterAntimicrobial Agents and Chemotherapy, 1985
- Ornithyl amphotericin methyl ester treatment of experimental candidiasis in ratsAntimicrobial Agents and Chemotherapy, 1984
- Correlation of in Vitro Susceptibility Test Results with in Vivo Response: Flucytosine Therapy in a Systemic Candidiasis ModelThe Journal of Infectious Diseases, 1983
- Treatment of Experimental Cryptococcal Meningitis with Amphotericin B, 5-Fluorocytosine, and KetoconazoleThe Journal of Infectious Diseases, 1982
- Amphotericin B and Amphotericin B Methyl Ester Ascorbate. I. Chemotherapeutic Activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in MiceThe Journal of Infectious Diseases, 1976
- Comparison of Amphotericin B and Amphotericin B Methyl Ester: Efficacy in Murine Coccidioidomycosis and ToxicityThe Journal of Infectious Diseases, 1976
- Comparative In Vitro Antifungal Activity of Amphotericin B and Amphotericin B Methyl EsterAntimicrobial Agents and Chemotherapy, 1975
- A Pharmacologic Guide to the Clinical Use of Amphotericin BThe Journal of Infectious Diseases, 1969